POST Online Media Lite Edition


Thailand and Indonesia plan to develop molnupiravir COVID-19 pill

Christian Fernsby |
Thailand’s health minister Anutin Charnvirakul said on Friday the country planned to develop the anti-viral pill molnupiravir to combat COVID-19 infections amid rising infections driven by the Omicron variant.

Article continues below


The molnupiravir COVID-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by Merck and Ridgeback Biotherapeutics.

The Southeast Asian nation intends to join other countries in the region also planning to make versions of the drug including Bangladesh and India.

“For molnupiravir, the Government Pharmaceutical Organization has plans to co-develop (this drug) with the Chulabhorn Research Institute,” Minister Anutin Charnvirakul told a news conference.

“A committee will research and produce the reactants, which will be additional support for future events,” he said.

Separately, Indonesia’s health minister Budi Gunadi Sadikin said on Friday the country also planned to develop molnupiravir in partnership with pharmaceutical company PT. Amarox Pharma Global starting in April or May.

What to read next

Iran, Indonesia target $2 billion in trade
Biodiesel: Indonesia files dispute against EU
Indonesia, South Korea signed economic cooperation deal